These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26935981)

  • 1. Putative modifier genes in mevalonate kinase deficiency.
    Marcuzzi A; Vozzi D; Girardelli M; Tricarico PM; Knowles A; Crovella S; Vuch J; Tommasini A; Piscianz E; Bianco AM
    Mol Med Rep; 2016 Apr; 13(4):3181-9. PubMed ID: 26935981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMAB, a novel candidate gene to be screened in the molecular diagnosis of Mevalonate Kinase Deficiency.
    Mezzavilla M; Moura RR; Celsi F; Tricarico PM; Crovella S
    Rheumatol Int; 2018 Jan; 38(1):121-127. PubMed ID: 29234874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRID2 a novel gene possibly associated with mevalonate kinase deficiency.
    Moura R; Tricarico PM; Campos Coelho AV; Crovella S
    Rheumatol Int; 2015 Apr; 35(4):657-9. PubMed ID: 25146332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of Prenylated Proteins, Autophagy Impairment and Apoptosis in SH-SY5Y Neuronal Cell Model of Mevalonate Kinase Deficiency.
    Tricarico PM; Romeo A; Gratton R; Crovella S; Celsi F
    Cell Physiol Biochem; 2017; 41(4):1649-1660. PubMed ID: 28359055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasculitis in a patient with mevalonate kinase deficiency (MKD): a case report.
    Omoyinmi E; Rowczenio D; Sebire N; Brogan PA; Eleftheriou D
    Pediatr Rheumatol Online J; 2021 Nov; 19(1):161. PubMed ID: 34809655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective Protein Prenylation in a Spectrum of Patients With Mevalonate Kinase Deficiency.
    Munoz MA; Jurczyluk J; Simon A; Hissaria P; Arts RJW; Coman D; Boros C; Mehr S; Rogers MJ
    Front Immunol; 2019; 10():1900. PubMed ID: 31474985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory deficiency in yeast mevalonate kinase deficient may explain MKD-associate metabolic disorder in humans.
    Santos MMS; Elsztein C; De Souza RB; Paiva SSL; Silva JA; Crovella S; De Morais MA
    Curr Genet; 2018 Aug; 64(4):871-881. PubMed ID: 29374778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel missense mutation in MVK associated with MK deficiency and dyserythropoietic anemia.
    Samkari A; Borzutzky A; Fermo E; Treaba DO; Dedeoglu F; Altura RA
    Pediatrics; 2010 Apr; 125(4):e964-8. PubMed ID: 20194276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency.
    Mandey SH; Schneiders MS; Koster J; Waterham HR
    Hum Mutat; 2006 Aug; 27(8):796-802. PubMed ID: 16835861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National survey of Japanese patients with mevalonate kinase deficiency reveals distinctive genetic and clinical characteristics.
    Tanaka T; Yoshioka K; Nishikomori R; Sakai H; Abe J; Yamashita Y; Hiramoto R; Morimoto A; Ishii E; Arakawa H; Kaneko U; Ohshima Y; Okamoto N; Ohara O; Hata I; Shigematsu Y; Kawai T; Yasumi T; Heike T
    Mod Rheumatol; 2019 Jan; 29(1):181-187. PubMed ID: 29451047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current advances in the understanding and treatment of mevalonate kinase deficiency.
    Esposito S; Ascolese B; Senatore L; Bosis S; Verrecchia E; Cantarini L; Rigante D
    Int J Immunopathol Pharmacol; 2014; 27(4):491-8. PubMed ID: 25572728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolutionary hypothesis of the Mevalonate Kinase Deficiency.
    Vuch J; Marcuzzi A; Bianco AM; Tommasini A; Zanin V; Crovella S
    Med Hypotheses; 2013 Jan; 80(1):67-9. PubMed ID: 23168296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and cellular consequences of mevalonate kinase deficiency.
    Politiek FA; Turkenburg M; Henneman L; Ofman R; Waterham HR
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167177. PubMed ID: 38636615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of mevalonate-5-phosphate using UPLC-MS/MS for determination of mevalonate kinase activity.
    Reitzle L; Maier B; Stojanov S; Teupser D; Muntau AC; Vogeser M; Gersting SW
    Clin Biochem; 2015 Aug; 48(12):781-7. PubMed ID: 25982894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incomplete mitophagy in the mevalonate kinase-deficient Saccharomyces cerevisiae and its relation to the MKD-related autoinflammatory disease in humans.
    Santos MMS; Gatica D; de Azêvedo Silva J; Crovella S; Klionsky DJ; De Morais MA
    Biochim Biophys Acta Mol Basis Dis; 2021 Apr; 1867(4):166053. PubMed ID: 33385519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches.
    De Leo L; Marcuzzi A; Decorti G; Tommasini A; Crovella S; Pontillo A
    Pharmacol Res; 2010 Jun; 61(6):506-10. PubMed ID: 20206266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, genetic, and therapeutic diversity in 2 patients with severe mevalonate kinase deficiency.
    Ruiz Gomez A; Couce ML; Garcia-Villoria J; Torres A; Baña Souto A; Yagüe J; Vilaseca MA; Ribes A; Aróstegui JI
    Pediatrics; 2012 Feb; 129(2):e535-9. PubMed ID: 22271696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mevalonate kinase deficiency].
    Galeotti C
    Rev Prat; 2023 Oct; 73(8):850-854. PubMed ID: 38354005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic diversity, disease progression, and pathogenicity of MVK missense variants in mevalonic aciduria.
    Brennenstuhl H; Nashawi M; Schröter J; Baronio F; Beedgen L; Gleich F; Jeltsch K; von Landenberg C; Martini S; Simon A; Thiel C; Tsiakas K; Opladen T; Kölker S; Hoffmann GF; Haas D;
    J Inherit Metab Dis; 2021 Sep; 44(5):1272-1287. PubMed ID: 34145613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged treatment with mevalonolactone induces oxidative stress response with reactive oxygen species production, mitochondrial depolarization and inflammation in human glioblastoma U-87 MG cells.
    Gratton R; Tricarico PM; Celsi F; Crovella S
    Neurochem Int; 2018 Nov; 120():233-237. PubMed ID: 29753116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.